Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

InMed Pharmaceuticals Inc. INM

Full chart Compare
Set alert

Price alert · INM

All alert types
15.56 USD +2.55 (+19.65%)

At closeNov 6, 2026, 4:00 PM EST

14.58 -0.98 -6.30%

After hours · Nov 6, 4:00 PM ET

13.70 Day range 16.44
6.15 52-week range 18.50
YTD
+46.79%
1 year
-8.74%

Revenue & Expenses

Other Income → Expenses: $465.98KExpenses → Selling, General & Admin: $5.80MExpenses → Research & Development: $3.22MExpenses → Other Operating Expenses: $219.60KExpenses → Income Tax: $7.10KGross Profit → Expenses: $1.10MRevenue → Gross Profit: $1.10MRevenue → Cost of Revenue: $3.50MNet Loss → Expenses: $7.68MOther Income$465.98KGross Profit$1.10MNet Loss$7.68MCost of Revenue$3.50MExpenses$9.24MSelling, General & Admin$5.80MResearch & Development$3.22MOther Operating Expenses$219.60KIncome Tax$7.10KRevenue$4.60M

Latest period ending Jun 30, 2026 · select a line to chart its full history

Income statement

Full income statement How to read it
INM annual income statement
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
-11.55M-8.45M-8.13M-8.38M-17.26M
-12.56M-8.16M-7.68M-7.95M-18.60M
-31.20-84.00-201.00-650.00-6,634.00

Balance sheet

Full balance sheet How to read it
INM annual balance sheet
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
2.19M10.74M6.57M8.91M6.18M
3.03M15.58M11.82M14.11M12.79M
1.96M2.15M2.62M2.02M3.71M
1.08M13.43M9.21M12.09M9.08M

Cash flow

Full cash flow How to read it
INM annual cash flow
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
-8.64M-8.10M-6.99M-7.28M-15.58M
94.50K12.27M4.65M10.68M15.07M
-8.55M4.17M-2.34M2.74M-1.19M